- Home
- BCYC vs VHI Comparison
BCYC vs VHI Comparison
Compare BCYC & VHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- VHI
- Stock Information
- Founded
- BCYC 2009
- VHI 1932
- Country
- BCYC United Kingdom
- VHI United States
- Employees
- BCYC N/A
- VHI N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- VHI Major Chemicals
- Sector
- BCYC Health Care
- VHI Industrials
- Exchange
- BCYC Nasdaq
- VHI Nasdaq
- Market Cap
- BCYC 565.5M
- VHI 454.3M
- IPO Year
- BCYC 2019
- VHI N/A
- Fundamental
- Price
- BCYC $8.76
- VHI $14.07
- Analyst Decision
- BCYC Buy
- VHI Sell
- Analyst Count
- BCYC 11
- VHI 1
- Target Price
- BCYC $22.91
- VHI $12.00
- AVG Volume (30 Days)
- BCYC 284.7K
- VHI 13.1K
- Earning Date
- BCYC 10-31-2025
- VHI 11-06-2025
- Dividend Yield
- BCYC N/A
- VHI 2.23%
- EPS Growth
- BCYC N/A
- VHI 269.89
- EPS
- BCYC N/A
- VHI 3.44
- Revenue
- BCYC $19,281,000.00
- VHI $2,093,500,000.00
- Revenue This Year
- BCYC N/A
- VHI $22.20
- Revenue Next Year
- BCYC N/A
- VHI $7.66
- P/E Ratio
- BCYC N/A
- VHI $4.17
- Revenue Growth
- BCYC N/A
- VHI 4.04
- 52 Week Low
- BCYC $6.10
- VHI $13.65
- 52 Week High
- BCYC $25.39
- VHI $41.75
- Technical
- Relative Strength Index (RSI)
- BCYC 56.40
- VHI 41.60
- Support Level
- BCYC $7.65
- VHI $14.35
- Resistance Level
- BCYC $8.75
- VHI $15.31
- Average True Range (ATR)
- BCYC 0.45
- VHI 0.56
- MACD
- BCYC -0.03
- VHI 0.05
- Stochastic Oscillator
- BCYC 55.56
- VHI 41.52
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About VHI Valhi Inc.
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.